Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFFITOPE AD02 Follow-up Study in Alzheimer's Disease
NCT02008513Phase 2Terminated
- Sponsor
- AFFiRiS
- Start
- Jun 2013
- Primary completion
- Sep 2014
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Peptides
- Countries
- 6
01
Overview
A Phase 2 trial of affitope ad02 in Alzheimer's disease (AD), sponsored by AFFiRiS. Started Jun 2013; status: terminated.
02
Drugs
affitope ad02
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02008513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008513.